Lars2 Deficiency-Induced Mitochondrial Dysfunction Drives the Emergence of a Pro-Inflammatory Stroke-Specific

Qing Zou1, Jianxin Zhou1, Ying Li1

  • 1School of Life Sciences, Shanghai University, Shanghai, China.

Aging and Disease
|July 18, 2025
PubMed

Insights

Stroke triggers a distinct microglial subset (Mc) with low leucyl-tRNA synthetase 2 (Lars2) expression and pro-inflammatory features. Lars2 deficiency impairs mitochondrial repair, driving neuroinflammation post-stroke.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglial immune status is altered post-stroke, extending beyond M1/M2 classifications.
  • Stroke induces changes in mitochondrial autophagy and assembly processes in microglia.

Purpose of the Study:

  • To identify novel microglial subsets and molecular mechanisms involved in post-stroke neuroinflammation.
  • To investigate the role of leucyl-tRNA synthetase 2 (Lars2) in microglial function and response to stroke.

Main Methods:

  • Single-cell RNA sequencing of mouse striatal microglia after hemorrhagic and ischemic stroke.
  • Gene Ontology functional enrichment analysis and cell-cell communication analysis.
  • In vitro experiments involving Lars2 overexpression and conditioned media treatments.

Main Results:

  • A distinct microglial subset (Mc) with low Lars2 expression was identified post-stroke.
  • Lars2 deficiency correlated with impaired mitochondrial function and increased pro-inflammatory cytokine release.
  • The pleiotrophin-syndecan-4 (PTN-SDC4) pathway was identified as a key mediator in neuron-Mc communication.

Conclusions:

  • Mc represents a stroke-induced pro-inflammatory microglial population characterized by low Lars2 expression.
  • Lars2 acts as a mitochondrial checkpoint, linking microglial reprogramming to neuroinflammation after stroke.
  • Targeting Lars2 or the PTN-SDC4 pathway may offer therapeutic strategies for stroke recovery.